"From January 20 onwards, we have gifted over 55 lakh doses of vaccines to our neighbouring countries and in our extended neighbourhood," Srivastava said.
He said Bhutan has been supplied 1.5 lakh doses so far and Maldives one lakh doses. Nepal and Bangladesh were given 10 lakh and 20 lakh doses respectively.
Srivastava said Myanmar received 15 lakh doses, Mauritius one lakh doses and Seychelles got 50,000 doses.
"These supplies are based on requests from these countries," he said.
Over the next few days, Srivastava said India plans to "gift" one lakh doses to Oman, five lakh doses to CARICOM countries and two lakh doses to Nicaragua. The Pacific Island states are also getting two lakh doses.
The Caribbean Community (CARICOM) is a grouping of 20 island nations which are home to approximately 16 million people.
"In line with the prime minister's announcement that India sees international cooperation in the fight against the COVID-19 pandemic as its duty, we have played the role of the first responder in our neighbourhood as well as undertaken supplies to countries beyond," Srivastava said.
He said commercial exports have taken place to Brazil, Morocco and Bangladesh and further such supplies are likely to be made to Saudi Arabia, South Africa, Canada and Mongolia.
"Further, we are going to supply 1 crore doses to Africa and 10 lakh to UN health workers under GAVI's COVAX facility," he said.
GAVI is a global vaccine alliance.
"Our external supplies, whether as gifts or on a commercial basis, are based on domestic availability, licensing issues and regulatory approvals in the countries concerned," he added.
Srivastava said India will continue to supply vaccines to partner countries over the coming weeks and months in a phased manner.
"Decisions on these supplies will, of course, be calibrated against the requirements of the roll-out of the COVID-19 vaccine at home," he said.
In a major announcement, India had said on January 19 it would send COVID-19 vaccines under grant assistance to Bhutan, Maldives, Bangladesh, Nepal, Myanmar and Seychelles from January 20 and supplies to Sri Lanka, Afghanistan and Mauritius would commence after confirmation of necessary regulatory clearances.
India is one of the world's biggest drug-makers, and an increasing number of countries have already approached it for procuring the coronavirus vaccines.
India has already rolled out a massive coronavirus vaccination drive under which two vaccines, Covishield and Covaxin, are being administered to frontline health workers across the country.
While Oxford-AstraZeneca's Covishield is being manufactured by the Serum Institute, Covaxin is being produced by Bharat Biotech.
India had earlier supplied hydroxychloroquine, Remdesivir and paracetamol tablets, as well as diagnostic kits, ventilators, masks, gloves and other medical supplies to a large number of countries to help them deal with the pandemic.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.